Nutraceutical sees rise in Q4 sales
Nutraceutical posted a net income of $3.54m for the fourth quarter 2010, or $0.34 per diluted share, compared to net income of $3.19m, or $0.29 per diluted share,
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.